September 18, 2013
Noriatsu Kono, Head of Health Ministry's Clinical Trial Promotion Office A health ministry official condemned the manipulation of data on Novartis Pharma’s hypertension drug Diovan (valsartan) at a symposium in Chiba Prefecture on September 16, saying that the scandal even...read more